Delos Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525 | Buy |
+1
| New | +$525 | ﹤0.01% | 253 |
|
|
2024
Q3 | – | Sell |
-6
| Closed | -$6.31K | – | 325 |
|
|
2024
Q2 | $6.31K | Hold |
6
| – | – | 0.01% | 145 |
|
|
2024
Q1 | $5.78K | Buy |
6
+4
| +200% | +$3.85K | 0.01% | 152 |
|
|
2023
Q4 | $1.76K | Sell |
2
-52
| -96% | -$45.7K | ﹤0.01% | 140 |
|
|
2023
Q3 | $44.6K | Hold |
54
| – | – | 0.05% | 74 |
|
|
2023
Q2 | $38.8K | Hold |
54
| – | – | 0.05% | 73 |
|
|
2023
Q1 | $44.4K | Hold |
54
| – | – | 0.06% | 67 |
|
|
2022
Q4 | $39K | Hold |
54
| – | – | 0.06% | 67 |
|
|
2022
Q3 | $37K | Buy |
54
+2
| +4% | +$1.37K | 0.04% | 62 |
|
|
2022
Q2 | $31K | Hold |
52
| – | – | 0.03% | 69 |
|
|
2022
Q1 | $36K | Hold |
52
| – | – | 0.04% | 80 |
|
|
2021
Q4 | $33K | Buy |
+52
| New | +$33K | 0.03% | 99 |
|